Symbols / VSEE $0.28 +2.63%
VSEE Chart
About
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 11.99M |
| Enterprise Value | 18.99M | Income | -10.07M | Sales | 14.43M |
| Book/sh | -0.33 | Cash/sh | 0.01 | Dividend Yield | — |
| Payout | 0.00% | Employees | 154 | IPO | — |
| P/E | 0.60 | Forward P/E | — | PEG | — |
| P/S | 0.83 | P/B | -0.85 | P/C | — |
| EV/EBITDA | -2.93 | EV/Sales | 1.32 | Quick Ratio | 0.14 |
| Current Ratio | 0.16 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | 0.46 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 18.70% | Earnings | — | ROA | -25.97% |
| ROE | — | ROIC | — | Gross Margin | 54.78% |
| Oper. Margin | -51.69% | Profit Margin | -69.81% | Shs Outstand | 43.24M |
| Shs Float | 20.75M | Short Float | 3.76% | Short Ratio | 2.34 |
| Short Interest | — | 52W High | 2.52 | 52W Low | 0.23 |
| Beta | 0.50 | Avg Volume | 736.04K | Volume | 112.31K |
| Target Price | — | Recom | None | Prev Close | $0.27 |
| Price | $0.28 | Change | 2.63% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.27
Latest analyst target
3. DCF / Fair value
$0.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.27
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-02-24 | init | Maxim Group | — → Buy | $5 |
- VSEE - VSee Health, Inc. Latest Stock News & Market Updates - Stock Titan hu, 15 Jan 2026 08
- CapEx per share of VSee Health, Inc. – NASDAQ:VSEEW - TradingView Wed, 11 Mar 2026 22
- VSee Health establishes Series B preferred stock with conversion and liquidation terms - Investing.com hu, 11 Dec 2025 08
- VSee Health Shareholders Approve Major Warrant-Linked Equity Issuance - TipRanks ue, 03 Mar 2026 08
- Hospital bedside robot aims to ease staffing crunch: VSee AI debuts - Stock Titan ue, 10 Mar 2026 13
- VSee Health stock soars after securing FedRAMP High authorization - Investing.com ue, 28 Oct 2025 07
- VSEE Health (VSEE) director receives 40,107-share stock grant - Stock Titan Fri, 06 Mar 2026 08
- VSee Health stock soars after FedRAMP authorization and ICU robotics push - Investing.com ue, 11 Nov 2025 08
- VSEE director David Wickersham awarded 40,107 company shares (VSEE) - Stock Titan hu, 05 Mar 2026 08
- [Form 4] VSEE HEALTH, INC. Insider Trading Activity - Stock Titan hu, 05 Mar 2026 08
- VSee Health (NASDAQ: VSEE) investors back private placement share issuance - Stock Titan ue, 03 Mar 2026 21
- VSee Health (NASDAQ: VSEE) iDoc Executes Contracts, Builds $3M Hospital Pipeline - Stock Titan ue, 25 Nov 2025 08
- VSee Health (Nasdaq: VSEE) gains HHS FedRAMP High ATO, enabling use by other agencies - Stock Titan ue, 28 Oct 2025 07
- VSee Health (NASDAQ: VSEE) signs teleradiology contract projected ~$10M, ARR doubling - Stock Titan ue, 21 Oct 2025 07
- VSee Health (Nasdaq: VSEE) eliminates $5M+ legacy SPAC debt, aiding NASDAQ compliance - Stock Titan hu, 23 Oct 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 40107 | 12152 | — | Stock Award(Grant) at price 0.30 per share. | METZGER SCOTT | Director | — | 2026-03-04 00:00:00 | D |
| 1 | 40107 | 12152 | — | Stock Award(Grant) at price 0.30 per share. | LOWDERMILK KEVIN | Director | — | 2026-03-04 00:00:00 | D |
| 2 | 40107 | 12152 | — | Stock Award(Grant) at price 0.30 per share. | O'SULLIVAN COLIN P. | Director | — | 2026-03-04 00:00:00 | D |
| 3 | 40107 | 12152 | — | Stock Award(Grant) at price 0.30 per share. | WICKERSHAM DAVID L. | Director | — | 2026-03-04 00:00:00 | D |
| 4 | 40107 | 12152 | — | Stock Award(Grant) at price 0.30 per share. | FAIRFAX CYDONII V. | Director | — | 2026-03-04 00:00:00 | D |
| 5 | 865167 | 311586 | — | Conversion of Exercise of derivative security at price 0.32 - 0.65 per share. | WICKERSHAM DAVID L. | Director | — | 2026-02-23 00:00:00 | I |
| 6 | 68624 | 45013 | — | Stock Award(Grant) at price 0.64 - 0.69 per share. | METZGER SCOTT | Director | — | 2025-09-19 00:00:00 | D |
| 7 | 68624 | 45013 | — | Stock Award(Grant) at price 0.64 - 0.69 per share. | LOWDERMILK KEVIN | Director | — | 2025-09-19 00:00:00 | D |
| 8 | 560724 | 86863 | — | Stock Award(Grant) at price 0.00 - 0.64 per share. | LEONARD JERRY | Chief Financial Officer | — | 2025-09-19 00:00:00 | D |
| 9 | 68624 | 45013 | — | Stock Award(Grant) at price 0.64 - 0.69 per share. | O'SULLIVAN COLIN P. | Director | — | 2025-09-19 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.44M | 23.37K | -58.96K | 37.24K |
| TaxRateForCalcs | 0.03 | 0.21 | 0.21 | 0.28 |
| NormalizedEBITDA | -5.82M | -1.81M | -1.31M | 253.27K |
| TotalUnusualItems | -51.94M | 111.26K | -280.76K | 133.08K |
| TotalUnusualItemsExcludingGoodwill | -51.94M | 111.26K | -280.76K | 133.08K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -57.70M | -3.76M | -836.21K | 475.90K |
| ReconciledDepreciation | 1.38M | 678.00 | ||
| ReconciledCostOfRevenue | 3.24M | 1.93M | 1.54M | 1.41M |
| EBITDA | -57.75M | -1.69M | -1.59M | 386.34K |
| EBIT | -59.13M | -1.70M | -1.59M | 386.34K |
| NetInterestIncome | -211.46K | -191.32K | -31.87K | 0.00 |
| InterestExpense | 211.46K | 191.32K | 31.87K | 0.00 |
| NormalizedIncome | -7.20M | -3.85M | -614.41K | 380.06K |
| NetIncomeFromContinuingAndDiscontinuedOperation | -57.70M | -3.76M | -836.21K | 475.90K |
| TotalExpenses | 15.10M | 7.55M | 7.84M | 7.09M |
| TotalOperatingIncomeAsReported | -62.15M | -1.87M | -1.68M | 252.28K |
| DilutedAverageShares | 14.69M | 14.69M | 14.69M | |
| BasicAverageShares | 14.69M | 14.69M | 14.69M | |
| DilutedEPS | -0.26 | -0.06 | 0.03 | |
| BasicEPS | -0.26 | -0.06 | 0.03 | |
| DilutedNIAvailtoComStockholders | -57.70M | -3.76M | -836.21K | 475.90K |
| NetIncomeCommonStockholders | -57.70M | -3.76M | -836.21K | 475.90K |
| NetIncome | -57.70M | -3.76M | -836.21K | 475.90K |
| MinorityInterests | 0.00 | -37.48K | 89.55K | 197.67K |
| NetIncomeIncludingNoncontrollingInterests | -57.70M | -3.73M | -925.75K | 278.23K |
| NetIncomeContinuousOperations | -57.70M | -3.73M | -925.75K | 278.23K |
| TaxProvision | -1.64M | 1.84M | -694.36K | 108.11K |
| PretaxIncome | -59.34M | -1.89M | -1.62M | 386.34K |
| OtherIncomeExpense | -54.45M | 91.15K | -124.24K | 134.06K |
| OtherNonOperatingIncomeExpenses | -2.51M | -20.11K | 156.52K | 986.00 |
| SpecialIncomeCharges | -58.11M | 21.06K | -216.03K | 133.08K |
| OtherSpecialCharges | 645.98K | -107.86K | 216.03K | -133.08K |
| ImpairmentOfCapitalAssets | 56.68M | 0.00 | ||
| RestructuringAndMergernAcquisition | 792.80K | 86.80K | 216.03K | 0.00 |
| GainOnSaleOfSecurity | 6.18M | 90.20K | -64.73K | |
| NetNonOperatingInterestIncomeExpense | -211.46K | -191.32K | -31.87K | 0.00 |
| TotalOtherFinanceCost | 2.51M | |||
| InterestExpenseNonOperating | 211.46K | 191.32K | 31.87K | 0.00 |
| OperatingIncome | -4.68M | -1.79M | -1.46M | 252.28K |
| OperatingExpense | 11.86M | 5.62M | 6.30M | 5.67M |
| SellingGeneralAndAdministration | 11.86M | 5.62M | 6.30M | 5.67M |
| GeneralAndAdministrativeExpense | 11.86M | 5.62M | 6.30M | 5.67M |
| OtherGandA | 6.55M | 1.20M | 1.28M | 780.24K |
| SalariesAndWages | 5.31M | 4.42M | 5.02M | 4.89M |
| GrossProfit | 7.18M | 3.83M | 4.84M | 5.92M |
| CostOfRevenue | 3.24M | 1.93M | 1.54M | 1.41M |
| TotalRevenue | 10.42M | 5.77M | 6.38M | 7.34M |
| OperatingRevenue | 10.42M | 5.77M | 6.38M | 7.34M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 16.30M | 14.69M | 14.69M | 14.69M |
| ShareIssued | 16.30M | 14.69M | 14.69M | 14.69M |
| NetDebt | 7.96M | 424.27K | 286.47K | |
| TotalDebt | 9.55M | 543.00K | 517.13K | |
| TangibleBookValue | -15.93M | -3.97M | 360.56K | 1.20M |
| InvestedCapital | 8.26M | -3.43M | 877.69K | 1.20M |
| WorkingCapital | -15.99M | -4.30M | -1.85M | -234.74K |
| NetTangibleAssets | -15.93M | -3.97M | 360.72K | 1.20M |
| CapitalLeaseObligations | 1.26M | 0.00 | ||
| CommonStockEquity | -18.49K | -3.97M | 360.56K | 1.20M |
| PreferredStockEquity | 1.00 | 160.00 | 160.00 | |
| TotalCapitalization | -18.49K | -3.97M | 360.72K | 1.20M |
| TotalEquityGrossMinorityInterest | -18.49K | -4.30M | -2.03K | 923.72K |
| MinorityInterest | 0.00 | -325.28K | -362.75K | -273.21K |
| StockholdersEquity | -18.49K | -3.97M | 360.72K | 1.20M |
| RetainedEarnings | -67.70M | -10.00M | -5.67M | -4.83M |
| AdditionalPaidInCapital | 67.68M | 6.03M | 6.03M | 6.03M |
| CapitalStock | 1.63K | 464.00 | 1.16K | 1.16K |
| CommonStock | 1.63K | 464.00 | 1.00K | 1.00K |
| PreferredStock | 1.00 | 0.00 | 160.00 | 160.00 |
| TotalLiabilitiesNetMinorityInterest | 20.01M | 5.11M | 2.61M | 1.01M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.00M | 0.00 | 0.00 | 0.00 |
| NonCurrentDeferredLiabilities | 137.38K | 0.00 | ||
| NonCurrentDeferredRevenue | 70.00K | 0.00 | ||
| NonCurrentDeferredTaxesLiabilities | 67.38K | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 863.28K | 0.00 | ||
| LongTermCapitalLeaseObligation | 863.28K | 0.00 | ||
| CurrentLiabilities | 19.01M | 5.11M | 2.61M | 1.01M |
| OtherCurrentLiabilities | 333.54K | 735.00K | 273.53K | |
| CurrentDeferredLiabilities | 417.81K | 902.52K | 956.56K | 810.05K |
| CurrentDeferredRevenue | 417.81K | 902.52K | 956.56K | 810.05K |
| CurrentDebtAndCapitalLeaseObligation | 8.68M | 543.00K | 517.13K | |
| CurrentCapitalLeaseObligation | 401.67K | 0.00 | ||
| CurrentDebt | 8.28M | 543.00K | 517.13K | |
| OtherCurrentBorrowings | 6.25M | 543.00K | 110.00K | |
| LineOfCredit | 536.10K | 0.00 | ||
| CurrentNotesPayable | 1.50M | 0.00 | 407.13K | 0.00 |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.18M | 1.24M | ||
| PayablesAndAccruedExpenses | 7.40M | 1.68M | 867.41K | 202.45K |
| CurrentAccruedExpenses | 1.88M | 167.57K | ||
| InterestPayable | 558.36K | 52.03K | ||
| Payables | 5.51M | 1.52M | 867.41K | 202.45K |
| OtherPayable | 179.01K | |||
| DuetoRelatedPartiesCurrent | 51.90K | 338.51K | 146.32K | 0.00 |
| TotalTaxPayable | 999.55K | 761.87K | ||
| AccountsPayable | 4.28M | 416.80K | 721.09K | 202.45K |
| TotalAssets | 19.99M | 805.79K | 2.61M | 1.94M |
| TotalNonCurrentAssets | 16.97M | 3.66K | 1.85M | 1.16M |
| NonCurrentDeferredAssets | 1.85M | 1.16M | ||
| NonCurrentDeferredTaxesAssets | 1.85M | 1.16M | ||
| GoodwillAndOtherIntangibleAssets | 15.91M | 0.00 | ||
| OtherIntangibleAssets | 10.99M | |||
| Goodwill | 4.92M | 0.00 | ||
| NetPPE | 1.06M | 3.66K | ||
| AccumulatedDepreciation | -272.73K | -678.00 | ||
| GrossPPE | 1.33M | 4.33K | ||
| Leases | 6.60K | 0.00 | ||
| OtherProperties | 859.72K | 1.00K | ||
| MachineryFurnitureEquipment | 33.06K | 3.33K | ||
| BuildingsAndImprovements | 433.17K | 0.00 | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 3.02M | 802.13K | 759.78K | 777.75K |
| OtherCurrentAssets | 446.83K | 79.92K | 139.66K | 145.22K |
| Receivables | 2.25M | 603.48K | 389.45K | 286.09K |
| DuefromRelatedPartiesCurrent | 531.66K | 0.00 | ||
| AccountsReceivable | 1.72M | 603.48K | 389.45K | 286.09K |
| AllowanceForDoubtfulAccountsReceivable | -2.39M | -32.46K | ||
| GrossAccountsReceivable | 4.11M | 635.94K | ||
| CashCashEquivalentsAndShortTermInvestments | 326.12K | 118.73K | 230.66K | 346.44K |
| CashAndCashEquivalents | 326.12K | 118.73K | 230.66K | 346.44K |
| CashFinancial | 326.12K | 118.73K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -5.84M | -636.93K | -825.78K | -459.80K |
| RepaymentOfDebt | -707.35K | 0.00 | ||
| IssuanceOfDebt | 5.46M | 390.00K | 710.00K | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 31.00K | ||
| CapitalExpenditure | -55.27K | -4.33K | ||
| InterestPaidSupplementalData | 111.33K | 0.00 | 0.00 | 0.00 |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 16.00K | 17.97K |
| EndCashPosition | 326.12K | 118.73K | 230.66K | 346.44K |
| BeginningCashPosition | 118.73K | 230.66K | 346.44K | 775.24K |
| ChangesInCash | 207.38K | -111.93K | -115.78K | -428.80K |
| FinancingCashFlow | 6.02M | 525.00K | 710.00K | 31.00K |
| CashFlowFromContinuingFinancingActivities | 6.02M | 525.00K | 710.00K | 31.00K |
| NetOtherFinancingCharges | 1.27M | 135.00K | ||
| NetCommonStockIssuance | 0.00 | 31.00K | ||
| CommonStockIssuance | 0.00 | 31.00K | ||
| NetIssuancePaymentsOfDebt | 4.75M | 390.00K | 710.00K | 0.00 |
| NetShortTermDebtIssuance | 5.18M | 190.00K | 710.00K | 0.00 |
| ShortTermDebtPayments | -280.71K | 0.00 | ||
| ShortTermDebtIssuance | 5.46M | 190.00K | 710.00K | 0.00 |
| NetLongTermDebtIssuance | -426.63K | 200.00K | ||
| LongTermDebtPayments | -426.63K | 0.00 | ||
| LongTermDebtIssuance | 0.00 | 200.00K | ||
| InvestingCashFlow | -26.14K | -4.33K | ||
| CashFlowFromContinuingInvestingActivities | -26.14K | -4.33K | ||
| NetBusinessPurchaseAndSale | 29.12K | 0.00 | ||
| SaleOfBusiness | 29.12K | 0.00 | ||
| NetPPEPurchaseAndSale | -55.27K | -4.33K | ||
| PurchaseOfPPE | -55.27K | -4.33K | ||
| OperatingCashFlow | -5.79M | -632.60K | -825.78K | -459.80K |
| CashFlowFromContinuingOperatingActivities | -5.79M | -632.60K | -825.81K | -459.80K |
| ChangeInWorkingCapital | -3.21M | 1.31M | 4.15K | -604.96K |
| ChangeInOtherWorkingCapital | -414.71K | -104.04K | -547.88K | -767.17K |
| ChangeInOtherCurrentLiabilities | -92.87K | 0.00 | ||
| ChangeInPayablesAndAccruedExpense | -1.66M | 1.60M | 664.96K | -108.79K |
| ChangeInPayable | -1.66M | 1.60M | 664.96K | -108.79K |
| ChangeInAccountPayable | -1.45M | 1.41M | 518.64K | -108.79K |
| ChangeInPrepaidAssets | -202.25K | 59.74K | 5.56K | -101.94K |
| ChangeInReceivables | -839.81K | -246.48K | -118.49K | 372.95K |
| ChangesInAccountReceivables | -1.09M | -246.48K | -118.49K | 372.95K |
| OtherNonCashItems | 105.00K | -14.13K | 15.96K | -133.08K |
| StockBasedCompensation | 896.54K | 0.00 | ||
| UnrealizedGainLossOnInvestmentSecurities | -6.18M | -90.20K | ||
| ProvisionandWriteOffofAssets | 759.78K | 32.46K | 15.13K | 0.00 |
| AssetImpairmentCharge | 56.68M | 0.00 | ||
| DeferredTax | -1.68M | 1.85M | ||
| DeferredIncomeTax | -1.68M | 1.85M | ||
| DepreciationAmortizationDepletion | 1.38M | 678.00 | ||
| DepreciationAndAmortization | 1.38M | 678.00 | ||
| Depreciation | 1.38M | 678.00 | ||
| OperatingGainsLosses | 3.16M | 64.73K | ||
| GainLossOnInvestmentSecurities | 2.51M | 64.73K | ||
| NetIncomeFromContinuingOperations | -57.70M | -3.73M | -925.75K | 278.23K |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for VSEE
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|